Possibilities of chemotherapy in the treatment of prostate cancer
dc.contributor.author | Richter Igor | cs |
dc.contributor.author | Dvořák Josef | cs |
dc.contributor.author | Bartoš Jiří | cs |
dc.date.accessioned | 2018-09-25T12:18:22Z | |
dc.date.available | 2018-09-25T12:18:22Z | |
dc.date.issued | 2017 | cs |
dc.format.extent | 6 | cs |
dc.identifier.issn | 0862-495X | cs |
dc.identifier.uri | https://dspace.tul.cz/handle/15240/31803 | |
dc.language.iso | cze | cs |
dc.publisher | Ambit Media | cs |
dc.publisher.city | Brno | cs |
dc.relation.ispartofseries | 0 | cs |
dc.subject | prostate cancer | cs |
dc.subject | metastasis | cs |
dc.subject | chemotherapy | cs |
dc.subject | docetaxel | cs |
dc.subject | cabazitaxel | cs |
dc.title | Possibilities of chemotherapy in the treatment of prostate cancer | en |
dc.title | Možnosti chemoterapie v léčbě karcinomu prostaty | cs |
local.citation.epage | 28-33 | cs |
local.citation.spage | 28-33 | cs |
local.identifier.publikace | 5272 | |
local.relation.issue | 1 | cs |